formerly Helomics
Biotechnology
Website
Company Tagline
As a part of Predictive Oncology, our mission is to change the landscape of oncology drug discovery.
Industry Category
Business Keywords
Company Description
Formerly Helomics, now a vital component of Predictive Oncology, is dedicated to revolutionizing oncology drug discovery. Located in Pittsburgh, Pennsylvania, the company operates a cutting-edge research laboratory focused on advancing cancer therapeutics. Formerly Helomics aims to significantly impact personalized cancer care through innovative technologies and comprehensive research efforts.
As a part of Predictive Oncology, Formerly Helomics leverages its expertise in computational biology, gene signatures, and machine learning to develop groundbreaking oncology solutions. The company's CLIA-certified clinical laboratory ensures the highest standards in biomarker testing and the development of effective cancer therapeutics. With a strong foundation in cancer research and a commitment to innovation, Formerly Helomics is positioned to transform the future of oncology drug discovery.
With its primary address at 91 43rd Street, Pittsburgh, Pennsylvania 15201, US, Formerly Helomics is actively contributing to advancements in cancer therapeutics and personalized care. Formerly Helomics utilizes its extensive biobank of tumor samples and expertise in biomarker development to deliver impactful results. We invite the management team of Formerly Helomics to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and market reach.
Key Personnel / Employees
Compare Companies Side by Side
Compare formerly Helomics with 3 companies in Biotechnology
| Comparison Field |
formerly HelomicsMain Company |
SIB Swiss Institute...View Profile |
QuantoriView Profile |
ArctorisView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1998 | 2018 | 2016 |
|
Company Size
|
— | 201-500 | 501-1,000 | 11-50 |
|
City
|
Pittsburgh, Pennsylvania | Lausanne, Vaud | Cambridge, Massachusetts | Abingdon, Oxfordshire, England |
|
Country
|
United States | Switzerland | United States | |
|
Skills & Keywords
Comparing with main company
|
23 Total Skills
oncology drug discovery
cancer research
biomarker testing
personalized cancer care
computational biology
gene signatures
machine learning
Gene Signatures
CLIA lab
heterogeneity
drug discovery
characterized tumor samples
CSRA Testing
AI
assays
Biomarker Testing
small molecule
Gynecologic Cancers
Personalized Cancer Care
Cancer Therapeutics
drug development
biomarker development
biobank of tumor samples
|
16 Total
16 Unique
Unique Skills:
bioinformatics
Bioinformatics analysis
Data science
Data stewardship
genomics
glycomics
+10
|
20 Total
20 Unique
Unique Skills:
algorithms
clinical trial design
cloud computing
computer software
covid-19
data analytics
+14
|
18 Total
18 Unique
Unique Skills:
antibodies
automation
biochemistry
biophysics
Biotech
cell biology
+12
|
4
Total Companies1998
Oldest Founded2
Countries74
Unique SkillsSimilar Companies
Other organizations in the same industry
Sterilab Services
BiotechnologyA specialist diagnostic company dedicated to providing high quality solutions for healthcare profess...
Universal Ibogaine Inc. (TSXV: IBO)
BiotechnologyTransforming addiction treatment with ibogaine as a central piece of the solution.
Alternative Company Names
This company is also known as